Exact Sciences expects to raise $50 million through additional stock offering

Exact Sciences Corp. wants to raise $50 million to get its test for colon cancer ready to go to market, even though it will be more than a year before that happens, in the best of circumstances. Read full Wisconsin State Journal story here.